In summary, our results indicate that acidosis and IFN-γ-mediated PD-L1 expression on cancer cells represents a previously undescribed novel immune escape mechanism that can be targeted by therapeutic blockade of the PD-L1/PD-1 axis. This evidence concerns the gene CD274 and cancer.